Lana Medical Co. (9587.SR) — Income statement
Revenue, gross profit, operating income, net income, and EPS for Lana Medical Co. — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 92↑9.8% | 84↑72.9% | 49↑19.2% | 41↑27.6% | 32 | |
| Cost of Revenue | 71↑20.7% | 59↑101.2% | 29↑34.2% | 22↑35.6% | 16 | |
| Gross Profit | 21↓16.3% | 25↑29.6% | 19↑1.8% | 19↑19.5% | 16 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 10↑33.5% | 8↓0.9% | 8↑16.9% | 7 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 4↑0.7% | 4↑39.2% | 3↑69.4% | 2 | |
| SG&A Expenses | 0.00↓100.0% | 31↑96.0% | 16↑47.6% | 11↑27.0% | 8 | |
| Other Expenses | 15↑203.7% | -14↓526.6% | 3↑89.7% | 2↑42.0% | 1 | |
| Operating Expenses | 15↓9.8% | 16↓13.6% | 19↑53.6% | 12↑28.9% | 10 | |
| Total Costs & Expenses | 86↑14.1% | 76↑71.4% | 44↑29.0% | 34↑39.0% | 25 | |
| Operating Results | ||||||
| Operating Income | 6↓36.6% | 10↑3065.1% | 0.30↓95.4% | 7↓10.3% | 7 | |
| Depreciation & Amortization | 0.00↓100.0% | 4↑78.5% | 2↑29.0% | 2↑41.7% | 1 | |
| EBITDA | 6↓53.6% | 13↑579.7% | 2↓77.0% | 8↓6.6% | 9 | |
| EBIT | 6↓36.6% | 10↑27769.8% | -0.03↓100.5% | 7↓13.1% | 8 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↑100.0% | -0.80↓64.0% | -0.49↓76.0% | -0.28↓90.6% | -0.14 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00↓100.0% | 0.80↑64.0% | 0.49↑76.0% | 0.28↑90.6% | 0.14 | |
| Non-Operating Income | 0.00 | 0.00↓100.0% | 0.43 | 0.00 | 0.00 | |
| Other Income / Expenses | -6↓220.8% | 5↑712.2% | -0.83↓1536.3% | 0.06↓87.8% | 0.47 | |
| Income Before Tax | 0.00↓100.0% | 14↑2713.4% | -0.52↓107.9% | 7↓15.0% | 8 | |
| Income Tax Expense | 0.00↓100.0% | 1↓17.5% | 1↑24.7% | 1↓5.8% | 1 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 0.00↓100.0% | 12↑746.9% | -2↓135.1% | 5↓16.7% | 7 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 3↓66.3% | 8↑165.8% | 3↓45.2% | 5↓16.7% | 7 | |
| Bottom-Line Net Income | 3↓66.3% | 8↑515.4% | -2↓135.1% | 5↓16.7% | 7 | |
| EPS (Basic) | 0.05↓78.4% | 0.23↑650.0% | -0.04↓134.4% | 0.12↓39.3% | 0.20 | |
| EPS (Diluted) | 0.05↓78.4% | 0.23↑650.0% | -0.04↓134.4% | 0.12↓44.5% | 0.22 | |
| Weighted Average Shares | 54↓0.3% | 54↑18.5% | 46↑52.1% | 30↓8.6% | 33 | |
| Weighted Average Diluted Shares | 54↓0.3% | 54↑18.5% | 46↑52.1% | 30↓16.7% | 36 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.